A recent study, described as “Major” by the respected Journal ‘Clinical Infectious Diseases’, provides significant “in Vivo’ evidence that a common injecting technique of mRNA vaccine by medical staff can lead to Myopericarditis, or the swelling of heart tissues. This may lead to fatal cardiac events if undiagnosed and/or in patients with other cardiac-based conditions.
A study issued for publication in July 2021 and published on the 18th of August 2021 titled “Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model” , has shown strong causal links between the delivery technique of COVID19 mRNA vaccines and the development of inflammation of the pericardium (sac separating heart from surrounding organs etc), and swelling of the Myocardium, or heart muscle. This study was conducted on mice, and is thought a significant discovery.
The mRNA vaccine is supposed to be injected into muscle, and not intravenously or directly into the vein. In the United States, medical staff are being told by the Centre for Disease Control (CDC) not to ‘aspirate’ syringes before delivering the mRNA vaccine.
Aspirating a syringe means that the medical personnel delivering the vaccine draws back the plunger of the syringe when the needle has entered the tissue to ensure that they have not accidentally entered a blood vessel such as a vein, rather than muscle. If blood enters the syringe when it is drawn back, then a vein has been entered and the medical personnel should discard that syringe and try again until they are sure it is a muscle they are delivering the vaccine into.
The National Centre for Biotechnology Information describes aspiration as follows…
“An injection is defined by the World Health Organization (WHO) as parenteral administration of medication through a skin puncture via a syringe, while aspiration is defined as the pulling back of the plunger of a syringe (for 5–10 seconds) prior to injecting medicine 1– 4. Aspiration is most commonly performed during an intramuscular (IM) or subcutaneous (SC) injection, and is meant to ensure that the needle tip is located at the desired site, and has not accidentally punctured a blood vessel.”
In Ireland, the HSE recommends against aspirating before the delivery of vaccines. In their guidance to Nurses on aspiration and vaccine delivery the HSE says…
“Pulling back on the syringe plunger before injection to check for blood return? • Entrenched in nursing text books since 1930’s • No evidence to support this practice • Aspiration not recommended (No reports that injecting into a vein has even happened)” (https://www.hse.ie/…/hcpinfo/conference/5confaug12.pdf
The Major study revealing a strong link between mRNA vaccine delivery and myopericarditis (link below) opens by making clear the authors are in favour of vaccination, but their data does raise concerns about delivery technique.
The researchers cited a study by CM Thomas et al (2016) indicating that accidental injection into blood vessels rather than muscle is a common occurrence…
“However, a self-reporting study of registered nurses showed that 40% reported blood aspiration at least once, and 4% reported blood aspiration 13 times or more during intramuscular injection. The finding suggests that inadvertent intravenous injection of vaccine is possible.”
The study found that not only did the mice that were delivered mRNA vaccine intravenously develop symptoms of myopericarditis on their first dose, but that damage was “grossly’ visible” after the second dose on examination of the mice-hearts.
The findings are a new addition to the plethora of studies developed around COVID-19, and the findings may go somewhat to explaining at least a some of the increases in vaccine injury since the introduction of COVID-19 vaccines (as reported to VAERS).
Below is a link to the study.